179 related articles for article (PubMed ID: 34286514)
81. Identification of long noncoding RNA expression profile in oxaliplatin-resistant hepatocellular carcinoma cells.
Yin X; Zheng SS; Zhang L; Xie XY; Wang Y; Zhang BH; Wu W; Qiu S; Ren ZG
Gene; 2017 Jan; 596():53-88. PubMed ID: 27729273
[TBL] [Abstract][Full Text] [Related]
82. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
Jing Z; Ye X; Ma X; Hu X; Yang W; Shi J; Chen G; Gong L
Cancer Med; 2020 Jun; 9(12):4324-4338. PubMed ID: 32324343
[TBL] [Abstract][Full Text] [Related]
83. LncRNA CRNDE promotes hepatocellular carcinoma cell proliferation, invasion, and migration through regulating miR-203/ BCAT1 axis.
Ji D; Jiang C; Zhang L; Liang N; Jiang T; Yang B; Liang H
J Cell Physiol; 2019 May; 234(5):6548-6560. PubMed ID: 30230527
[TBL] [Abstract][Full Text] [Related]
84. LINC01343 targets miR-526b-5p to facilitate the development of hepatocellular carcinoma by upregulating ROBO1.
Wu S; Tang T; Zhou H; Huang J; Kang X; Zhang J
Sci Rep; 2023 Oct; 13(1):17282. PubMed ID: 37828032
[TBL] [Abstract][Full Text] [Related]
85. LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma cells.
Sun J; Zheng X; Wang B; Cai Y; Zheng L; Hu L; Lu X; Xie S; Zhang X; Liu H; Ye L
Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(2):261-270. PubMed ID: 35130616
[TBL] [Abstract][Full Text] [Related]
86. Extract of
Huang X; Chen Y; Zhang X; Li F; Ye H
Cancer Biother Radiopharm; 2020 Oct; 35(8):586-595. PubMed ID: 32486841
[No Abstract] [Full Text] [Related]
87. NEAT1 upregulates TGF-β1 to induce hepatocellular carcinoma progression by sponging hsa-mir-139-5p.
Tu J; Zhao Z; Xu M; Lu X; Chang L; Ji J
J Cell Physiol; 2018 Nov; 233(11):8578-8587. PubMed ID: 29797561
[TBL] [Abstract][Full Text] [Related]
88. A curcumin analog GL63 inhibits the malignant behaviors of hepatocellular carcinoma by inactivating the JAK2/STAT3 signaling pathway via the circular RNA zinc finger protein 83/microRNA-324-5p/cyclin-dependent kinase 16 axis.
Zhao JA; Nie W; Dong L; Liu W; Wei W
J Gastroenterol Hepatol; 2021 Oct; 36(10):2967-2977. PubMed ID: 33982329
[TBL] [Abstract][Full Text] [Related]
89. Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis.
Liu W; Yin C; Liu Y
Cancer Biother Radiopharm; 2021 Dec; 36(10):863-878. PubMed ID: 32673066
[No Abstract] [Full Text] [Related]
90. LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1.
Tu J; Zhao Z; Xu M; Chen M; Weng Q; Ji J
Biomed Pharmacother; 2019 Oct; 118():109213. PubMed ID: 31376654
[TBL] [Abstract][Full Text] [Related]
91. LINC00205, a YY1-modulated lncRNA, serves as a sponge for miR-26a-5p facilitating the proliferation of hepatocellular carcinoma cells by elevating CDK6.
Cheng T; Yao Y; Zhang S; Zhang XN; Zhang AH; Yang W; Hou CZ
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6208-6219. PubMed ID: 34730201
[TBL] [Abstract][Full Text] [Related]
92. MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3.
Li Z; Wu L; Tan W; Zhang K; Lin Q; Zhu J; Tu C; Lv X; Jiang C
Ann Hepatol; 2021; 23():100345. PubMed ID: 33812045
[TBL] [Abstract][Full Text] [Related]
93. Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis.
Ji D; Wang Y; Sun B; Yang J; Luo X
Biochem Biophys Res Commun; 2019 Jun; 513(3):669-674. PubMed ID: 30982576
[TBL] [Abstract][Full Text] [Related]
94. [LncRNA HULC promots HCC growth by downregulating miR-29].
Zhu LR; Feng JL; Liu XJ; Wang JM
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
[No Abstract] [Full Text] [Related]
95. Circular RNA circLRCH3 promotes oxaliplatin resistance in gastric cancer through the modulation of the miR-383-5p/FGF7 axis.
Xiang C; Li R; Qiu H; Zuo E; Zhang Y; Shan L; Cheng X
Histol Histopathol; 2023 Jun; 38(6):647-658. PubMed ID: 35920365
[TBL] [Abstract][Full Text] [Related]
96. A review on the role of PCGEM1 lncRNA in cancer.
Ghafouri-Fard S; Khoshbakht T; Hussen BM; Baniahmad A; Taheri M; Mokhtari M
Pathol Res Pract; 2022 Dec; 240():154223. PubMed ID: 36403313
[TBL] [Abstract][Full Text] [Related]
97. LncRNA CCAT1 enhances chemoresistance in hepatocellular carcinoma by targeting QKI-5.
Xia C; Sun Y; Li Y; Ma J; Shi J
Sci Rep; 2022 May; 12(1):7826. PubMed ID: 35552451
[TBL] [Abstract][Full Text] [Related]
98. LncRNA PCGEM1 promotes colorectal cancer cell proliferation and migration in positive feedback loop through PCGEM1/miR-433-3p/CTCF axis.
Xu W; Wu L; Lu H; Xiang X; Wang F; Li S
Pathol Res Pract; 2022 Sep; 237():154017. PubMed ID: 35872368
[TBL] [Abstract][Full Text] [Related]
99. Blood exosome marker miRNA-30d-5p: Role and regulation mechanism in cell stemness and gemcitabine resistance of hepatocellular carcinoma.
Tang B; Xie L; Tang X; Tian J; Xiao S
Mol Cell Probes; 2023 Oct; 71():101924. PubMed ID: 37536457
[TBL] [Abstract][Full Text] [Related]
100. Dampening HOTAIR sensitizes the gastric cancer cells to oxaliplatin through miR-195-5p and ABCG2 pathway.
Luo Y; Lu X; Ma W; Xiao Y; Wei C; Yuan X; Wu Y; Wang Y; Xiong Y; Yu X; Wu X; He S; Liu Y; Wang J; Wu Q; Zhou H; Jiang Z
J Cell Mol Med; 2023 Nov; 27(22):3591-3600. PubMed ID: 37621132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]